Please use this identifier to cite or link to this item: http://hdl.handle.net/11452/29128
Title: Syndecan-1 (CD138) expression in acute myeloblastic leukemia cells - An immuno electron microscopic study
Authors: Şeftalioğlu, Aysel
Karakuş, Sema
Dündar, Semra
Can, Belgin
Erdemli, Esra
Irmak, Mehmet Kemal
Öztaş, Emin
Korkmaz, Cem
Yazar, Fatih
Uludağ Üniversitesi/Tıp Fakültesi/Histoloji ve Embriyoloji Anabilim Dalı.
Çavuşoğlu, İlkin
56009155800
Keywords: Oncology
Heparan-sulfate proteoglycan
Acute lymphoblastic-leukemia
Bone-marrow
Stroma
Molecular-cloning
Migration
Adhesion
Biopsy
Bone
Cells
Electron microscopy
Myeloblastic leukemia cells
Tumors
Issue Date: 2003
Publisher: Taylor and Francis
Citation: Şeftalioğlu, A. vd. (2003). “Syndecan-1 (CD138) expression in acute myeloblastic leukemia cells - An immuno electron microscopic study”. Acta Oncologica, 42(1), 71-74.
Abstract: Syndecan-1 (CD138), an important transmembrane heparan sulfate proteoglycan is expressed in distinct stages of cell differentiation. Although its expression in acute lymphoblastic leukemia (ALL) cells is well known; its function or presence in acute myeloblastic leukemia (AML) cells is still largely unknown. The expression of syndecan-1 was studied in bone marrow biopsies of three patients with AML using electron microscopic immunocytochemistry. Positive expression of syndecan-1 was found in AML cells. These results suggest that syndecan-1 expression is not only a characteristic phenotypic marker for ALL, but is also expressed in AML cells.
URI: https://doi.org/10.1080/0891060310002267
https://www.tandfonline.com/doi/abs/10.1080/0891060310002267?cookieSet=1
http://hdl.handle.net/11452/29128
ISSN: 0284-186X
Appears in Collections:Scopus
Web of Science

Files in This Item:
File Description SizeFormat 
Çavuşoğlu_vd_2003.pdf2.34 MBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons